Krka profits down at nine-months as price squeezing bites
This article was originally published in Scrip
Executive Summary
Slovenian drugmaker Krka has reported a 4% decline in nine-month profits to $155 million. It also announced plans for a new listing on the Warsaw stock exchange before end of June next year. The company is currently listed on the Ljubljana Stock Exchange in its home territory, Slovenia.